Additionally, aspirin, a modulator of PTGS2, has long been recognized for its chemopreventive effect in the setting of colorectal cancers (76) and was recently demonstrated to reduce the development of colonic adenomas after F. nucleatum inoculation in the Apcmin/+ mouse model (77). This evidence concerns the gene PTGS2 and colorectal cancer.